LETROZOLE DEXCEL

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

LETROZOLE

Dostupno od:

DEXCEL LTD, ISRAEL

ATC koda:

L02BG04

Farmaceutski oblik:

FILM COATED TABLETS

Sastav:

LETROZOLE 2.5 MG

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapijska grupa:

LETROZOLE

Područje terapije:

LETROZOLE

Terapijske indikacije:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Datum autorizacije:

2016-02-29